Contact Us

Defective Medical Devices
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date when device was implanted :

Please describe any problems or injuries caused by the product:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Bard Avaulta Mesh Complications

bard avaulta

AddThis Social Bookmark Button

Bard Avaulta Transvaginal Mesh Complications Lawsuit

Bard Avaulta Transvaginal Mesh Complications, Side Effects, Lawsuit | Transvaginal Mesh, Pelvic Mesh, Surgical Mesh, Pelvic Sling | Lawsuits, Lawyer, Attorney | Side Effects: Bleeding, Pelvic Pain, Infection, Surgical Mesh Infection, Vaginal Epithelium Erosion, Erosion of Vaginal Tissue, Mesh Erosion, Pain, Incontinence, Urinary Problems, Prolapse, Bowel Perforation, Bladder Perforation, Blood Vessel Perforation, Pressure or “fullness” in the lower abdomen, Dyspareunia, Painful Sexual Intercourse, Vaginal bleeding Vaginal infections, Vaginal pain not related to intercourse, Vaginal Scarring, Neuropathic Numbness Or Weakness | Impaired Healing, Complications, Revision Surgery For Pelvic Organ Prolapse (POP) or Stress Urinary Incontinence (SUI)


If you received the C.R. Bard Avaulta mesh system during surgery to repair pelvic prolapse or treat urinary incontinence, you may be at risk for erosion, extrusion, hardening and shrinkage of the mesh materials. This can cause severe and persistent pain, infection and the need for additional surgical procedures to remove the Bard Avaulta mesh.

A growing number of lawsuits over the Bard Avaulta vaginal mesh have been filed in courts throughout the US. These lawsuits allege that C.R. Bard was negligent in the product’s design and in failing to warn patients of possible complications with Bard Avaulta mesh. Some doctors have also been named in these lawsuits, which also claim that the Bard Avaulta mesh was improperly and negligently implanted in patients.

It is believed that the Bard Avaulta surgical mesh design inhibits surrounding tissue from receiving nutrients and oxygen, causing impaired healing. This can lead to complications that may require further surgery.

Possible Bard Avaulta Complications and Injuries:

  • Erosion of the mesh through the vaginal tissue
  • Exposure or extrusion of mesh, which can require multiple surgeries
  • Feeling a lump in the vaginal opening or something protruding from vagina
  • Painful sexual intercourse
  • Perforation or puncture of the bladder, intestines and bowels, as well as blood vessels around the vaginal wall
  • Recurrent Pelvic Organ Prolapse (POP)
  • Recurrent Stress Urinary Incontinence (SUI)
  • Urinary problems
  • Vaginal bleeding
  • Vaginal chronic drainage, discharge and infections
  • Vaginal pain
  • Vaginal scarring and shortening

Complete Bard Avaulta mesh removal often requires multiple surgical procedures and results in scarring of pelvic tissue and muscles. Unfortunately, complications from the implantation of a Bard Avaulta mesh can lead to a serious decline in the patient's quality of life.

C.R. Bard Avaulta MultiDistrict Litigation (MDL)

In October 2010, the U.S. Judicial Panel on Multidistrict Litigation consolidated all federal lawsuits involving C.R. Bard's Avaulta Biosynthetic, Avaulta Plus and Avaulta Solo transvaginal mesh products in a multidistrict litigation (MDL), the Avaulta Pelvic Support Systems Product Liability Litigation (MDL 2187). The C.R. Bard Avaulta MDL is currently pending in U.S. District Court, Southern District of West Virginia before the Honorable Joseph R. Goodwin. Plaintiffs with lawsuits pending in the C.R. Bard Avaulta MDL allege that these surgical mesh devices were defectively designed and caused them to sustain serious injuries, including erosion, extrusion, dyspareunia, and pain. Plaintiffs further allege the defendants failed to warn of the extent and types of injuries, or that the discomfort caused by transvaginal mesh complications could be permanent, even after multiple corrective surgeries.

An MDL allows lawsuits associated with a particular product to be coordinated under one judge for pretrial litigation to avoid duplicative discovery, inconsistent rulings and to conserve the resources of the parties, witnesses and the court. When lawsuits are consolidated as a multidistrict litigation, each retains its own identity. If lawsuits in the C.R. Bard Avaulta MDL are not resolved, they will be transferred back to the court where they originated for trial.

Legal Help For Victims Affected By Bard Avaulta Mesh Complications

If you are among the women suffering because of the Bard Avaulta mesh, we can help. For a free legal consultation with one of our defective medical device attorneys, please fill out our online form or call 1 800 LAW INFO (1-800-529-4636) today or call us at 1-800-LAW-INFO (1-800-529-4636).

Bard Avaulta Mesh ComplicationsRSS Feed

Bard Avaulta Mesh Lawsuits Set for First Bellwether Trial

May 3, 2012 | Parker Waichman LLP
Litigation over C.R. Bard's Avaulta transvaginal mesh devices is moving ahead.  According to a report from Bloomberg News, the federal judge overseeing the Bard Avaulta transvaginal mesh multidistrict litigation has scheduled the first bellwether trial for February 3, 2013.About 600 Bard Avaulta transvaginal mesh lawsuits are pending in the multidistrict litigation before U.S. District Judge Joseph R. Goodwin.  Judge Goodwin is also overseeing multidistrict litigations involving other...

Transvaginal Mesh for POP Repair Should be Classified "High Risk," FDA Panel Says

Sep 9, 2011 | Parker Waichman LLP
An advisory panel for the U.S. Food & Drug Administration (FDA) voiced support for an agency proposal to reclassify transvaginal mesh devices used to repair pelvic organ prolapse (POP)  as high risk, or Class III.  If the FDA does go forward with the change, manufacturers of  would be required to conduct premarket clinical trials of transvaginal mesh devices before they could be marketed for POP surgery.Currently, transvaginal mesh devices are marketed as moderate risk, or...

Transvaginal Mesh Failures Prompt Lawsuits, FDA Review

Sep 8, 2011 | Parker Waichman LLP
Women around the country continue to file lawsuit over transvaginal mesh device failures following surgery to repair pelvic organ prolapse (POP).  In addition to hundreds of legal claims, the makers of transvaginal mesh products also face a regulatory review that could lead to tighter restrictions on their products.According to Bloomberg News, surgeons began using mesh products to repair abdominal hernias in the 1950s.  In 1996, the first transvaginal mesh device was approved to...

Transvaginal Mesh Products May Face Tougher Scrutiny

Sep 6, 2011 | Parker Waichman LLP
The U.S. Food & Drug Administration (FDA) is considering a proposal to revoke 510(k) approvals for transvaginal mesh devices.  If the agency follows through, makers of transvaginal mesh devices currently on the market might have to submit new data to the agency in order to keep them there.Transvaginal mesh products are used in the surgical treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI).  The devices were used in 75,000 transvaginal surgeries last...

More Bard Avaulta Mesh Complications News